Until recently I was the CSO and co-founder of Circuit-Bio LTD, a portfolio company in the biotech accelerator FutuRx. Prior to Circuit-Bio, I was the head of the immuno-oncology department at Aummune LTD (a spinoff from Augmanity Nano), where I led a team focused on developing personalized cancer treatments utilizing nucleic acids (DNA aptamers). My experience also includes a position as an R&D scientist at Diabest Botanical Drug LTD, a drug discovery company based on medicinal plants for type